ANAL CANCER MARKET ANALYSIS

Anal Cancer Market, by Drug Type (Fluorouracil, Cisplatin, Carboplatin, and Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)), by Cancer Type (Carcinoma In-situ, Squamous Cell Carcinoma, Melanoma, Adenocarcinoma, and Basal Cell Carcinoma), by Treatment Type (Chemotherapy, Surgery, Radiation Therapy, and Immunotherapy), by Distribution Channel (Hospitals & Clinics, Research & Academic Institutes, Long-term Care Centers, and Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Oct 2021
Code : CMI4701
Pages :154
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Anal Cancer Market Restraint

The side effects of chemotherapy drugs used in the treatment of anal cancer are the factors that are expected to hinder growth of the global anal cancer market over the forecast period. For instance, according to an article published by the American cancer Society in November 2017, some of the side effects associated with use of chemotherapy drugs in the treatment of anal cancer include nausea, vomiting, loss of appetite, hair loss, diarrhea, mouth sores, and others.